Lung Cancers Terminated Phase 2 Trials for Paclitaxel (DB01229)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Terminated2 IdentifierTitlePurposeDrugs
NCT00459121Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by SurgeryTreatment
NCT00526890Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTreatment
NCT00334763Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00290537Phase II Study of ZD6474 in Advanced NSCLCTreatment
NCT00063258Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung CancerTreatment